Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

F7888

Supelco

Fluocinolone acetonide 21-acetate

≥98%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C26H32F2O7
CAS Number:
356-12-7
Molecular Weight:
494.52
EC Number:
206-597-6
MDL number:
MFCD00079302
UNSPSC Code:
41116107
PubChem Substance ID:
24894952

assay

≥98%

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

forensics and toxicology
veterinary

format

neat

SMILES string

CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)[C@@]4(F)C(O)CC23C

Looking for similar products? Visit Product Comparison Guide

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

hcodes

H300,H361

Hazard Classifications

Acute Tox. 2 Oral - Repr. 2

Storage Class

6.1B - Non-combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Localized acral pityriasis lichenoides chronica: report of a case.
Jennifer J Halbesleben et al.
The Journal of dermatology, 38(8), 832-834 (2011-03-01)
Ginette A Hinds et al.
Dermatology online journal, 14(11), 11-11 (2008-12-20)
Disseminate and recurrent infundibulofolliculitis (DRIF) is an uncommon pruritic follicular eruption of unknown etiology that is predominantly seen in black men. This condition tends to affect the trunk and upper extremities and is usually unresponsive to local and systemic treatment.
Brad A Yentzer et al.
Cutis, 86(4), 208-213 (2010-12-15)
Variations in adherence may cause variations in treatment outcomes with topical corticosteroid therapy for atopic dermatitis. An intensive short course of outpatient treatment may promote good adherence and provide a high level of efficacy. The purpose of this study was
Matthew T Woods et al.
Journal of drugs in dermatology : JDD, 10(2), 171-176 (2011-02-02)
To determine the effect a novel formulation of fluocinonide cream on skin barrier function in subjects with atopic dermatitis. The authors performed an open-label, investigator-blinded, side-by-side, controlled trial examining skin barrier function before and after a two-week course of a
Tinea incognito.
Rhonda Lesniak
Dermatology nursing, 20(5), 403-404 (2008-12-06)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service